Pcas (PCA.PA) Stock Price

Pcas Price

🇫🇷CLOSED
8.00EUR
Market closed
Today +/-
Today %

Pcas (PCA.PA) Stock | ISIN FR0000053514 | WKN 936292. The current Pcas stock price is 8 EUR (2026). Market capitalization is 109.93 M EUR. Pcas operates in the Health sector.

Revenue has compounded at 0.9% per year over the past 19 years to 226.36 M EUR. Earnings per share have declined at 5.1% per year over the last 13 years. Pcas's net margin stands at -21.6%, down from -0.2% several years earlier. Pcas currently offers a dividend yield of about 0.75%. The payout ratio is around 14% of earnings.

Pcas stock price

Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Pcas over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Pcas stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Pcas's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Pcas Stock Price History
DatePcas Price
Access this data via the Eulerpool API

Pcas Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2003
191.7 M EUR
2.7 M EUR
-800,000 EUR
Jan 1, 2004
194.6 M EUR
8.7 M EUR
9.5 M EUR
Jan 1, 2005
213.1 M EUR
2.5 M EUR
-3.5 M EUR
Jan 1, 2006
178.3 M EUR
5.7 M EUR
1.2 M EUR
Jan 1, 2007
185.3 M EUR
8.9 M EUR
2.8 M EUR
Jan 1, 2008
168.4 M EUR
5.5 M EUR
-900,000 EUR
Jan 1, 2009
152.5 M EUR
4.4 M EUR
-1.1 M EUR
Jan 1, 2010
158.5 M EUR
3.5 M EUR
-4 M EUR
Jan 1, 2011
164.5 M EUR
4 M EUR
-2.8 M EUR
Jan 1, 2012
171.1 M EUR
11.4 M EUR
3 M EUR
Jan 1, 2013
164.9 M EUR
7.1 M EUR
3.5 M EUR
Jan 1, 2014
166.35 M EUR
6.99 M EUR
2.51 M EUR
Jan 1, 2015
179.09 M EUR
14.3 M EUR
8.99 M EUR
Jan 1, 2016
191.99 M EUR
13.29 M EUR
6.83 M EUR
Jan 1, 2017
218.27 M EUR
14.38 M EUR
6.15 M EUR

Pcas Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 16, 2026, 4:53 AM
 
REVENUE (M EUR)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M EUR)
NET INCOME (M EUR)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
20152016201720182019202020212022
179191218206200194187226
7.836.714.14-5.5-2.91-3-3.6120.86
45.8145.5544.9543.6940.541.2434.2232.74
8287989081806474
8660-13-14-40-48
300-257.69185.7120
14.0314.1714.1413.913.7413.7413.7413.74
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Pcas generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Pcas retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Pcas's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Pcas has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Pcas's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Pcas stock margins

The Pcas margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Pcas. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Pcas.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2003
46.43 %
1.41 %
-0.42 %
Jan 1, 2004
43.73 %
4.47 %
4.88 %
Jan 1, 2005
44.02 %
1.17 %
-1.64 %
Jan 1, 2006
44.76 %
3.2 %
0.67 %
Jan 1, 2007
45.12 %
4.8 %
1.51 %
Jan 1, 2008
44.66 %
3.27 %
-0.53 %
Jan 1, 2009
45.84 %
2.89 %
-0.72 %
Jan 1, 2010
42.71 %
2.21 %
-2.52 %
Jan 1, 2011
42.8 %
2.43 %
-1.7 %
Jan 1, 2012
44.3 %
6.66 %
1.75 %
Jan 1, 2013
42.69 %
4.31 %
2.12 %
Jan 1, 2014
42.58 %
4.2 %
1.51 %
Jan 1, 2015
46.11 %
7.99 %
5.02 %
Jan 1, 2016
45.46 %
6.92 %
3.56 %
Jan 1, 2017
45.18 %
6.59 %
2.82 %

Pcas Stock Revenue, EBIT, Earnings per Share

The Pcas earnings per share therefore indicates how much revenue Pcas has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2003
17.43 EUR
0.25 EUR
-0.07 EUR
Jan 1, 2004
17.69 EUR
0.79 EUR
0.86 EUR
Jan 1, 2005
19.37 EUR
0.23 EUR
-0.32 EUR
Jan 1, 2006
11.97 EUR
0.38 EUR
0.08 EUR
Jan 1, 2007
13.63 EUR
0.65 EUR
0.21 EUR
Jan 1, 2008
13.16 EUR
0.43 EUR
-0.07 EUR
Jan 1, 2009
11.64 EUR
0.34 EUR
-0.08 EUR
Jan 1, 2010
11.92 EUR
0.26 EUR
-0.3 EUR
Jan 1, 2011
12.19 EUR
0.3 EUR
-0.21 EUR
Jan 1, 2012
12.67 EUR
0.84 EUR
0.22 EUR
Jan 1, 2013
12.68 EUR
0.55 EUR
0.27 EUR
Jan 1, 2014
11.86 EUR
0.5 EUR
0.18 EUR
Jan 1, 2015
12.76 EUR
1.02 EUR
0.64 EUR
Jan 1, 2016
13.55 EUR
0.94 EUR
0.48 EUR
Jan 1, 2017
15.44 EUR
1.02 EUR
0.44 EUR

Pcas business model & stock analysis

Pcas SA is a French chemical company specializing in the development and production of chemical substances. It was founded in 1962 by a group of independent chemical engineers. The company has expanded its business areas over the years and now has four divisions: Materials Division, Fine Chemicals Division, Life Science Division, and Petrochemicals Division. The Materials Division focuses on manufacturing organic and inorganic materials such as polymers and specialty chemicals used in various industries including automotive and construction. The Fine Chemicals Division specializes in synthesizing pharmaceutical active ingredients used in medication production and new therapy development. Pcas SA offers a wide range of chemical compounds customized to customer needs. The Life Science Division is involved in the development and production of cell-based products used in diagnostics and pharmaceutical research. This division produces enzymes, specialized cells, proteins, and reagents. The Petrochemicals Division produces specialized polymer additives and tank cleaners used in petrochemical, refinery, and maritime industries. All divisions of Pcas SA prioritize customer satisfaction and quality assurance by implementing environmental and sustainability standards. The company is known for its ability to quickly and flexibly respond to customer needs and requirements, including production adjustments and the development of new products. Pcas SA invests in research and development, collaborating with leading research institutions and scientists to continuously improve and apply cutting-edge technologies. In addition to the mentioned divisions, Pcas SA also produces a wide range of chemical intermediates and specialty chemicals used in various industries such as cosmetics, food, photovoltaic, and electronics. Overall, Pcas SA is an innovative and versatile company known for its flexibility, quality assurance, and customer focus. It has earned a leading position in the international chemical industry through its high-quality products and services, as well as its commitment to sustainability and environmental protection.

Pcas SWOT Analysis

Strengths

One of the strengths of PCas SA is its strong brand reputation, built over many years of delivering high-quality products and services. This has earned the company a loyal customer base and helps drive sales.

PCas SA also benefits from a highly skilled and experienced workforce. This expertise allows the company to innovate and develop cutting-edge technologies, giving it a competitive advantage in the market.

Additionally, PCas SA has a robust distribution network, enabling efficient product delivery to customers both domestically and internationally. This helps the company reach a wide range of customers and expand its market share.

Weaknesses

One weakness of PCas SA is its heavy reliance on a single supplier for key components. Any disruption in the supply chain could lead to production delays and impact the company's ability to meet customer demand.

Another weakness is the lack of diversification in its product portfolio. PCas SA primarily focuses on a specific line of products, which makes it vulnerable to changes in market demand and consumer preferences.

Additionally, PCas SA has relatively high production costs due to its use of specialized materials and manufacturing processes. This can affect its pricing competitiveness compared to other companies in the industry.

Opportunities

PCas SA has an opportunity to expand its market presence by targeting emerging markets where there is a growing demand for its products. This could involve establishing strategic partnerships or opening new sales channels in these regions.

The increasing demand for environmentally friendly products presents an opportunity for PCas SA to develop and market eco-friendly alternatives. This could not only attract environmentally conscious customers but also align with regulatory trends promoting sustainability.

Furthermore, PCas SA can explore diversification into related industries or new product categories to reduce its reliance on a single product line. This would enable the company to tap into new revenue streams and mitigate risks associated with market fluctuations.

Threats

One potential threat to PCas SA is intense competition from both established players and new entrants in the market. This could lead to pricing pressure and erode the company's market share if it fails to differentiate its products and services effectively.

Another threat is the rapidly changing technological landscape. PCas SA needs to continually invest in research and development to stay at the forefront of innovation and ensure its products remain competitive and meet evolving customer expectations.

Additionally, economic downturns can significantly impact consumer spending and demand for PCas SA's products. It is crucial for the company to have contingency plans and effective cost management strategies in place to navigate such challenging periods.

Pcas Eulerpool Fair Value

Pcas historical P/E ratio, EBIT multiple, and P/S ratio

Pcas annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Pcas shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2003
11 M base_Shares
Jan 1, 2004
11 M base_Shares
Jan 1, 2005
11 M base_Shares
Jan 1, 2006
14.9 M base_Shares
Jan 1, 2007
13.6 M base_Shares
Jan 1, 2008
12.8 M base_Shares
Jan 1, 2009
13.1 M base_Shares
Jan 1, 2010
13.3 M base_Shares
Jan 1, 2011
13.5 M base_Shares
Jan 1, 2012
13.5 M base_Shares
Jan 1, 2013
13 M base_Shares
Jan 1, 2014
14.03 M base_Shares
Jan 1, 2015
14.03 M base_Shares
Jan 1, 2016
14.17 M base_Shares
Jan 1, 2017
14.14 M base_Shares

Pcas Dividend History

11 years of dividend payments

YearAnnual DividendYoY ChangePayments
20170.06EUR 50.0%
20160.12EUR 0.0%
20150.12EUR 77.1%
20030.53EUR 16.7%
20020.45EUR 20.0%
20010.38EUR 83.3%
20002.25EUR 81.3%
199912EUR 77.8%
19986.75EUR 21.6%
19975.55EUR 48.0%

Pcas dividend payout ratio

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2003
-544.21 %
Jan 1, 2004
19.3 %
Jan 1, 2005
19.3 %
Jan 1, 2006
19.3 %
Jan 1, 2007
19.3 %
Jan 1, 2008
19.3 %
Jan 1, 2009
19.3 %
Jan 1, 2010
19.3 %
Jan 1, 2011
19.3 %
Jan 1, 2012
19.3 %
Jan 1, 2013
19.3 %
Jan 1, 2014
19.3 %
Jan 1, 2015
19.05 %
Jan 1, 2016
24.89 %
Jan 1, 2017
13.95 %
Price targets and forecasts for Pcas are not yet available.

Pcas shareholder structure

% Name
92.18563%
SK Capital Partners, LP
SK Capital Partners, LP
1.83823%
HMG Finance S.A.
HMG Finance S.A.
1.83355%
Inocap Gestion SAS
Inocap Gestion SAS
1.14118%
Gay-Lussac Gestion SAS
Gay-Lussac Gestion SAS
0.45956%
Norges Bank Investment Management (NBIM)
Norges Bank Investment Management (NBIM)
0.36386%
DEVK Versicherungen
DEVK Versicherungen
0.1744%
Sunny Asset Management
Sunny Asset Management
0.00073%
Lecourtier (Jacqueline)
Lecourtier (Jacqueline)
%
Claresco Finance S.A.
Claresco Finance S.A.

Pcas Executives and Management Board

JL

Ms. Jacqueline Lecourtier

(70)

Non-Executive Director

Compensation9,000 EUR
PL

Mr. Pierre Luzeau

(56)

Chairman of the Board, Chief Executive Officer · since 2017

PC

Mr. Philippe Clavel

Deputy Chief Executive Officer, Member of the Executive Committee

ST

Mr. Sebastien Taillemite

Deputy Chief Executive Officer, Member of the Executive Committee

EM

Mr. Eric Moissenot

General Manager, Assistant Finance and Administration, Member of the Executive Committee

Pcas Supply Chain

Frequently asked questions about Pcas

The business model of Pcas SA revolves around providing custom manufacturing and R&D services for specialty chemicals and pharmaceutical intermediates. Pcas SA specializes in developing, producing, and selling niche molecules and advanced chemical solutions for various industries, including pharmaceuticals, cosmetics, agrochemicals, and electronics. The company focuses on offering tailored solutions to meet specific customer needs, leveraging its expertise in synthesis, purification, and formulation. By emphasizing technological innovation and sustainable practices, Pcas SA aims to maintain its competitive edge and deliver high-quality products to its clients worldwide.

All fundamentals and in-depth analysis of Pcas

Our stock analysis for Pcas Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pcas Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.